277 related articles for article (PubMed ID: 25288144)
1. Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.
Phueanpinit P; Jarernsiripornkul N; Pongwecharak J; Krska J
Int J Clin Pharm; 2014 Dec; 36(6):1205-12. PubMed ID: 25288144
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.
Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
Prim Health Care Res Dev; 2018 Nov; 19(6):598-604. PubMed ID: 29551098
[TBL] [Abstract][Full Text] [Related]
3. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand.
Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
Expert Opin Drug Saf; 2016; 15(4):417-26. PubMed ID: 26742855
[TBL] [Abstract][Full Text] [Related]
4. Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients.
Phueanpinit P; Pongwecharak J; Sumanont S; Krska J; Jarernsiripornkul N
J Eval Clin Pract; 2017 Dec; 23(6):1387-1394. PubMed ID: 28809071
[TBL] [Abstract][Full Text] [Related]
5. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
6. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
[TBL] [Abstract][Full Text] [Related]
7. Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand.
Patsuree A; Krska J; Jarernsiripornkul N
Expert Opin Drug Saf; 2016; 15(3):287-95. PubMed ID: 26750422
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical care in Kuwait: hospital pharmacists' perspectives.
Katoue MG; Awad AI; Schwinghammer TL; Kombian SB
Int J Clin Pharm; 2014 Dec; 36(6):1170-8. PubMed ID: 25204259
[TBL] [Abstract][Full Text] [Related]
9. Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study.
Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
Int J Pharm Pract; 2019 Aug; 27(4):362-369. PubMed ID: 30912610
[TBL] [Abstract][Full Text] [Related]
10. Survey of healthcare professionals' practices, expectations, and attitudes towards provision of patient information leaflets in Thailand.
Jarernsiripornkul N; Nakboon S; Anarj K; Wongtaweepkij K
Int J Clin Pharm; 2020 Apr; 42(2):539-548. PubMed ID: 31955382
[TBL] [Abstract][Full Text] [Related]
11. Pharmacists' viewpoint towards their professional role in healthcare system: a survey of hospital settings of Pakistan.
Khan N; McGarry K; Naqvi AA; Iqbal MS; Haider Z
BMC Health Serv Res; 2020 Jul; 20(1):610. PubMed ID: 32615966
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
13. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand.
Jarernsiripornkul N; Chaisrisawadsuk S; Chaiyakum A; Krska J
Pharm World Sci; 2009 Oct; 31(5):559-564. PubMed ID: 19575308
[TBL] [Abstract][Full Text] [Related]
14. Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand.
Phueanpinit P; Pongwecharak J; Krska J; Jarernsiripornkul N
Int J Clin Pharm; 2016 Feb; 38(1):25-9. PubMed ID: 26582482
[TBL] [Abstract][Full Text] [Related]
15. A nationwide survey of methods and barriers to adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand.
Jarernsiripornkul N; Kayrash S; Homket P; Srisuriyachanchai W
Int J Pharm Pract; 2023 Dec; 31(6):625-632. PubMed ID: 37454288
[TBL] [Abstract][Full Text] [Related]
16. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
Watkins A; McKee J; Hughes C; Pfeiffenberger T
J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
[TBL] [Abstract][Full Text] [Related]
17. Community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia.
Selvaraj A; Redzuan AM; Hatah E
Int J Clin Pharm; 2020 Apr; 42(2):777-785. PubMed ID: 32006142
[TBL] [Abstract][Full Text] [Related]
18. Medication safety knowledge, attitude, and practice among hospital pharmacists in Lebanon.
Hallit S; Hajj A; Shuhaiber P; Iskandar K; Ramia E; Sacre H; Salameh P;
J Eval Clin Pract; 2019 Apr; 25(2):323-339. PubMed ID: 30592116
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
20. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
Sweis D; Wong IC
Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
